Bragar Eagel &amp; Squire, P.C., a shareholder rights law firm, reminds investors of DexCom, Inc. and Wildermuth Fund about upcoming deadlines to serve as lead plaintiff in class action lawsuits. The DexCom lawsuit alleges false and misleading statements about the G6 and G7 devices, while the Wildermuth Fund lawsuit claims miscalculation of investment fair value and intentional inflation of net asset value. Investors in both companies are encouraged to contact the firm regarding their rights.

德康医疗

<p>Bragar Eagel & Squire, P.C.，一家股东权益律师事务所，提醒 DexCom, Inc.和 Wildermuth Fund 的投资者注意即将到来的截止日期，以担任集体诉讼的主要原告。DexCom 的诉讼指控其关于 G6 和 G7 设备的虚假和误导性陈述，而 Wildermuth Fund 的诉讼则声称投资公允价值的错误计算和故意夸大净资产值。鼓励这两家公司的投资者联系该事务所以了解他们的权利</p>

Bragar Eagel & Squire, P.C. 敦促德康医疗和 Wildermuth 的投资者在即将到来的截止日期之前联系该公司，以了解他们的权利